Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inogatran")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drugERIKSSON, U. G; RENBERG, L; BREDBERG, U et al.Biopharmaceutics & drug disposition. 1998, Vol 19, Num 1, pp 55-64, issn 0142-2782Article

Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasmaLEURS, Judith; WISSING, Britt-Marie; NERME, Viveca et al.Thrombosis and haemostasis. 2003, Vol 89, Num 2, pp 264-271, issn 0340-6245, 8 p.Article

In vitro effects of inogatran, a selective low molecular weight thrombin inhibitorTEGER-NILSSON, A.-C; BYLUND, R; GUSTAFSSON, D et al.Thrombosis research. 1997, Vol 85, Num 2, pp 133-145, issn 0049-3848Article

An efficient preparation of the potent and selective pseudopeptide thrombin inhibitor, inogatranPREVILLE, P; HE, J. X; TARAZI, M et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 12, pp 1563-1566, issn 0960-894XArticle

Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein CLINDER, R; BLOMBÄCK, M; EGBERG, N et al.Thrombosis research. 1999, Vol 95, Num 2, pp 117-125, issn 0049-3848Article

Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: Comparison with inogatranLIGUO CHI; MERTZ, Thomas E; ROGERS, Karen L et al.Journal of thrombosis and thrombolysis. 2001, Vol 11, Num 1, pp 19-31, issn 0929-5305Article

Oral thrombin inhibitors : Challenges and progressKIMBALL, S. D.Handbook of experimental pharmacology. 1999, Vol 132, pp 367-396, issn 0171-2004Article

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery diseaseOLDGREN, J; LINDER, R; GRIP, L et al.European heart journal. 1999, Vol 20, Num 22, pp 1657-1666, issn 0195-668XArticle

Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitroMATTSSON, Christer; MENSCHIK-LUNDIN, Angela; NYLANDER, Sven et al.Thrombosis research. 2001, Vol 104, Num 6, pp 475-486, issn 0049-3848Article

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery diseaseLINDER, R; OLDGREN, J; EGBERG, N et al.European heart journal. 1999, Vol 20, Num 7, pp 506-518, issn 0195-668XArticle

Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary diseaseANDERSEN, K; DELLBORG, M.The American journal of cardiology. 1998, Vol 81, Num 8, pp 939-944, issn 0002-9149Article

Current developments in antithrombotic therapy: The role of antithrombin agentsBREDDIN, H. K.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 1-8, issn 1424-8832, 8 p., SUP3Conference Paper

Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancementSJÖSTRÖM, M; LINDFORS, L; UNGELL, A.-L et al.Pharmaceutical research. 1999, Vol 16, Num 1, pp 74-79, issn 0724-8741Article

A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients a double-blind, randomized, dose-finding studyEuropean heart journal. 1997, Vol 18, Num 9, pp 1416-1425, issn 0195-668XArticle

Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the ratELG, M; GUSTAFSSON, D; CARLSSON, S et al.Thrombosis research. 1999, Vol 94, Num 3, pp 187-197, issn 0049-3848Article

BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis : Comparisons with heparin, r-hirudin, hirulog, inogatran and argatrobanFINKLE, C. D; PIERRE, A. S; LEBLOND, L et al.Thrombosis and haemostasis. 1998, Vol 79, Num 2, pp 431-438, issn 0340-6245Article

Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosisURIUDA, Y; WANG, Q.-D; GRIP, L et al.Cardiovascular research. 1996, Vol 32, Num 2, pp 320-327, issn 0008-6363Article

Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysisCHEN, L. Y; NICHOLS, W. W; MATTSSON, C et al.Cardiovascular research. 1995, Vol 30, Num 6, pp 866-874, issn 0008-6363Article

Management of patients with acute coronary syndromes: What is the clinical role of direct thrombin inhibitors?EIKELBOOM, John W; FRENCH, John.Drugs (Basel). 2002, Vol 62, Num 13, pp 1839-1852, issn 0012-6667, 14 p.Article

Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery diseaseCULLBERG, Marie; ERIKSSON, Ulf G; LARSSON, Marita et al.British journal of clinical pharmacology. 2001, Vol 51, Num 1, pp 71-79, issn 0306-5251Article

The effects of oral and intravenous direct thrombin inhibitors on the size of photochemically induced cortical infarction in ratsMIKULSKI, Andrzej; ELG, Margareta; GUSTAFSSON, David et al.Thrombosis research. 2001, Vol 101, Num 6, pp 477-482, issn 0049-3848Article

The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosisELG, M; GUSTAFSSON, D; DEINUM, J et al.Thrombosis and haemostasis. 1997, Vol 78, Num 4, pp 1286-1292, issn 0340-6245Article

Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the ratERIKSSON, B. I; CARLSSON, S; HALVARSSON, M et al.Thrombosis and haemostasis. 1997, Vol 78, Num 5, pp 1404-1407, issn 0340-6245Article

  • Page / 1